Gene · 7323
UBE2D3: ubiquitin conjugating enzyme E2 D3
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. UBE2D3: ubiquitin conjugating enzyme E2 D3. Genes, record 7323. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/7323
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P61077 | Ubiquitin-conjugating enzyme E2 D3 | 147 | 47 | Ensembl, GeneID, HGNC |
Source UniProt
Patents109
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4650780 A2 | 2025-11-19 | 5196 | P61077 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 5196 | P61077 | Espacenet |
| JP 2023550743 A | 2023-12-05 | 72 | P61077 | Espacenet |
| US 11630109 B2 | 2023-04-18 | 33 | P61077 | Espacenet |
| US 11459613 B2 | 2022-10-04 | 54 | P61077 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 95133 | P61077 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 95134 | P61077 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 95136 | P61077 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 95139 | P61077 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 95140 | P61077 | Espacenet |
1 to 10 of 109
See all 109 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,290
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | UBE2D3 papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 6 | 2025 |
| R01CA132878 | Post-translational Modifications in DNA Damage Response: a Structural Perspective | 6 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 5 | 2025 |
| P30CA016056 | Roswell Park Cancer Center Support Grant | 5 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 5 | 2025 |
| R01CA074305 | Chemical Approaches to Cell Signaling Enzymes | 5 | 2025 |
| P01CA066996 | Development of Novel Therapeutic Strategies in Human Leukemias | 4 | 2025 |
| P30CA016087 | Cancer Center Support Grant | 4 | 2025 |
| P51OD011092 | Support for National Primate Research Center | 4 | 2025 |
| R01AG011085 | Ubiquitin‐mediated proteolysis and cell cycle control | 4 | 2025 |
1 to 10 of 1,290Source NIH's project files
See all 1,290 nih grantsPapers1,394
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cryo-EM structure, enzymatic activity and genome targeting of canonical PRC1. | Nat Struct Mol Biol | 2026 | 42736418 | PubTator, text mining | PubMed |
| M2‑TAM‑derived exosomal miR‑491‑3p modulates UBE2D3 and promotes the proliferation, migration and invasion of lung cancer cells. | Oncol Rep | 2026 | 42495775 | PubTator, text mining | PubMed |
| Small Structural Variations, Large Functional Consequences: Comparative Analysis Reveals Structural Control of Ubiquitylation Site Selection by BRCA1/BARD1. | bioRxiv | 2026 | 42427510 | PubTator, text mining | PubMed |
| Cytoplasmic lattices store developmentally poised degradative and cytoskeletal complexes in mammalian eggs. | Nat Struct Mol Biol | 2026 | 42426369 | PubTator, text mining | PubMed |
| Retraction Note: UBE2D3 regulated by WTAP-mediated m6A modification inhibits temozolomide chemosensitivity in glioblastoma. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | 42337166 | PubTator, text mining | PubMed |
| Dual IRE1 targets: Determinants of the cell fate? | FEBS J | 2026 | 42298872 | PubTator, text mining | PubMed |
Genetic associations between asthma and type 2 inflammatory diseases: Insights from pleiotropic loci and genes: shared genetics of Type 2 Iinflammatory diseases: Shared Genetics of Type 2 Inflammatory Diseases. | Hum Immunol | 2026 | 42143449 | PubTator, text mining | PubMed |
| Uncovering core stemness biomarkers in HBV-HCC through integrated multi-omics. | PLoS One | 2026 | 42133686 | PubTator, text mining | PubMed |
| NUDT21 Drives T-Cell Acute Lymphoblastic Leukemia Through Dual Regulation of Alternative Polyadenylation and Transcriptional Activation. | Adv Sci (Weinh) | 2026 | 41926643 | PubTator, text mining | PubMed |
| Molecular basis of oocyte cytoplasmic lattice assembly. | Nature | 2026 | 41845018 | PubTator, text mining | PubMed |
1 to 10 of 1,394
See all 1,394 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/7323
GET https://conductscience.org/api/genes/v1/7323/patents?page=2